Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 19 Antikörper

Der Maus Monoklonal Anti-Cytokeratin 19-Antikörper wurde für WB, IHC, IF, FACS und StM validiert. Er ist geeignet, Cytokeratin 19 in Proben von Human zu detektieren.
Produktnummer ABIN6939946

Kurzübersicht für Cytokeratin 19 Antikörper (ABIN6939946)

Target

Alle Cytokeratin 19 (KRT19) Antikörper anzeigen
Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))

Reaktivität

  • 296
  • 97
  • 76
  • 8
  • 7
  • 6
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 162
  • 149
  • 3
  • 2
  • 1
Maus

Klonalität

  • 167
  • 150
Monoklonal

Konjugat

  • 158
  • 35
  • 20
  • 12
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Dieser Cytokeratin 19 Antikörper ist unkonjugiert

Applikation

  • 224
  • 116
  • 98
  • 84
  • 74
  • 60
  • 47
  • 45
  • 41
  • 39
  • 33
  • 22
  • 7
  • 6
  • 5
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Staining Methods (StM)

Klon

KRT19-799
  • Spezifität

    Recognizes a protein of 40 kDa, identified as cytokeratin-19 (CK19), which is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50 % -60 % of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.

    Aufreinigung

    Purified by Protein A/G

    Immunogen

    Recombinant human KRT19 protein

    Isotyp

    IgG2a kappa
  • Applikationshinweise

    Positive Control: MCF-7, HeLa, Hep-G2 cells, Breast Cancer.

    Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (0.5-2 μg/mL),Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))

    Andere Bezeichnung

    KRT19

    Molekulargewicht

    40kDa

    Gen-ID

    3880

    UniProt

    P08727
Sie sind hier:
Chat with us!